Previous 10 | Next 10 |
The following slide deck was published by Misonix, Inc. in conjunction with this Read more ...
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announ...
CryoLife (NYSE: CRY ) has entered into an agreement with Misonix (NASDAQ: MSON ) whereby latter will have exclusive US commercialization rights for CryoLife's NeoPatch product to treat a broad range of indications outside of cardiac and vascular surgery. More news on: CryoLife, Inc....
ATLANTA , Dec. 19, 2019 /PRNewswire/ -- CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered into an agreement whereby Misonix (NASDAQ: MSON) will have exclusive US commercializat...
FARMINGDALE, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced to...
The following slide deck was published by Misonix, Inc. in conjunction with this Read more ...
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced to...
Misonix, Inc. (MSON) Q1 2020 Earnings Conference Call November 7, 2019 16:30 ET Company Participants Norberto Aja - Jaffoni & Collins Stavros Vizirgianakis - President, CEO & Director Joseph Dwyer - CFO, Treasurer & Secretary Conference Call Participants Alexand...
MISONIX (NASDAQ: MSON ): Q1 EPS of $0.17 may not be comparable to consensus of -$0.17. More news on: Misonix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
FARMINGDALE, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported fina...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the “Election Deadline...
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...